1
Plaintiff
1
Defendant
0
Accused
Products
2
Patents-in-Suit
761
Days in
Litigation

Complaint Unavailable
Cause of Action
Unknown
Market Sector
Biotech and Pharma
Court
Previously Presiding
Gregory M. Sleet (until 08/07/2015)
Outcome Summary
Patent Information
-
Infringement
Impax Laboratories Incorporated
- 2 Details
Accused Product | Patent # | Claim # | Outcome |
---|---|---|---|
Generic version of Adderall XR product | US 6,322,819 B1 | All Asserted Claims |
Infringement
Entry 235
|
Generic version of Adderall XR product | US 6,605,300 B1 | All Asserted Claims |
Infringement
Entry 235
|